SARS-CoV2
Showing 26 - 50 of 123
Sars-CoV2, Covid-19 Trial in Oklahoma City (mHealth Assessments)
Completed
- Sars-CoV2
- Covid-19
- mHealth Assessments
-
Oklahoma City, OklahomaStephenson Cancer Center
Jan 26, 2022
COVID, Sars-CoV2 Trial in Lexington (Ivermectin, Camostat Mesilate, Artemesia annua)
Terminated
- COVID
- Sars-CoV2
- Ivermectin
- +3 more
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Jan 18, 2022
COVID-19, Sars-CoV2 Trial in Madison (Rapid Onsite COVID-19 Detection)
Completed
- COVID-19
- Sars-CoV2
- Rapid Onsite COVID-19 Detection
-
Madison, WisconsinUniversity of Wisconsin
Jan 18, 2022
Sars-CoV2, Covid-19 Trial in Brazil, Canada (Peginterferon Lambda-1A, )
Recruiting
- Sars-CoV2
- Covid-19
- Peginterferon Lambda-1A
- placebo
-
Botucatu, Brazil
- +6 more
Jan 17, 2022
COVID-19, SARS-CoV2, Androgenetic Alopecia Trial in Brasilia (Proxalutamide, Standard of Care)
Completed
- COVID-19
- +5 more
- Proxalutamide
- Standard of Care
-
Brasilia, BrazilCorpometria Institute
Dec 8, 2021
SARS-CoV2, COVID-19 Trial in Antwerpen, Hasselt (Assessing antibody responses, neutralizing capacity and memory B-cell function)
Active, not recruiting
- SARS-CoV2
- COVID-19
- Assessing antibody responses, neutralizing capacity and memory B-cell function
-
Antwerpen, Belgium
- +1 more
Dec 7, 2021
Solid Tumor, Sars-CoV2, Hematological Malignancy Trial in New York (BMS-986253)
Terminated
- Solid Tumor
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 18, 2021
Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)
Completed
- Sars-CoV2
- COVID
- Enoxaparin
- Prophylactic/Intermediate Dose Enoxaparin
-
Newark, New Jersey
- +5 more
Nov 17, 2021
Sars-CoV2 Trial in Manhasset, New Hyde Park (COVID-19 PCR and Serology)
Completed
- Sars-CoV2
- COVID-19 PCR and Serology
-
Manhasset, New York
- +1 more
Nov 4, 2021
Covid-19, Sars-CoV2 Trial in Los Angeles, Baltimore (Multiple Doses of Anti-SARS-CoV-2 convalescent plasma)
Terminated
- Covid-19
- Sars-CoV2
- Multiple Doses of Anti-SARS-CoV-2 convalescent plasma
-
Los Angeles, California
- +1 more
Nov 1, 2021
COVID, Covid-19, Corona Virus Infection Trial in Ventura (Ivermectin, Doxycycline Hcl, Zinc)
Active, not recruiting
- COVID
- +6 more
- Ivermectin
- +4 more
-
Ventura, CaliforniaProgenaBiome
Oct 26, 2021
COVID-19, SARS-CoV2 Trial in Miami Beach, Omaha, Sioux Falls (SAB-185, Normal Saline)
Active, not recruiting
- COVID-19
- SARS-CoV2
- SAB-185
- Normal Saline
-
Miami Beach, Florida
- +2 more
Oct 25, 2021
COVID-19, Coronavirus Infection, Sars-CoV2 Trial in Ventura (Hydroxychloroquine, Vitamin C, Vitamin D)
Recruiting
- COVID-19
- +7 more
- Hydroxychloroquine
- +3 more
-
Ventura, CaliforniaProgenaBiome
Oct 19, 2021
SARS-CoV2, COVID Trial in Rio De Janeiro, Patna, Vellore
Recruiting
- SARS-CoV2
- COVID
-
Rio De Janeiro, Brazil
- +2 more
Sep 30, 2021
SARS-CoV2 Trial in Ribeirão Preto (Cannabidiol, PLACEBO)
Active, not recruiting
- SARS-CoV2
- Cannabidiol
- PLACEBO
-
Ribeirão Preto, SP, Brazil
- +1 more
Sep 27, 2021
SARS-CoV2, Covid19 Trial in Herston (MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg, MF59 adjuvanted SARS-CoV-2 Sclamp vaccine
Active, not recruiting
- SARS-CoV2
- Covid19
- MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg
- +3 more
-
Herston, Queensland, AustraliaNucleus Network Brisbane (Q-Pharm Pty Ltd)
Aug 23, 2021
Postural Recruitment Maneuver in Acute Respiratory Distress
Completed
- Sars-CoV2
- ARDS
- Lateral Position (left and right lateral decubitus)
-
Jesús María, Lima, PeruHospital Rebagliati
Aug 23, 2021
COVID-19, Sars-CoV2 Trial in San Francisco (COVID-19 Convalescent Plasma (CCP), Placebo)
Completed
- COVID-19
- Sars-CoV2
- COVID-19 Convalescent Plasma (CCP)
- Placebo
-
San Francisco, California
- +2 more
Aug 23, 2021
COVID, Covid-19, Coronavirus Trial in Minsk (Allogenic pooled olfactory mucosa-derived mesenchymal stem cells, Standard
Completed
- COVID
- +6 more
- Allogenic pooled olfactory mucosa-derived mesenchymal stem cells
- Standard treatment according to the Clinical protocols
-
Minsk, BelarusInstitute of Biophysics and Cell Engineering of National Academy
Aug 20, 2021
COVID-19 Brain Injury
Completed
- Sars-CoV2
- +7 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Aug 13, 2021
COVID-19, Sars-CoV2, Pneumonia Trial in Richmond (Mavrilimumab, Placebos)
Completed
- COVID-19
- +2 more
- Mavrilimumab
- Placebos
-
Richmond, VirginiaVirginia Commonwealth University
Aug 4, 2021
Sars-CoV2 Trial in Besancon (biological samples day of delivery)
Completed
- Sars-CoV2
- biological samples day of delivery
-
Besancon, FranceChu Besancon
Aug 2, 2021